BEVACIZUMAB-AWWB

4692 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

BEVACIZUMAB-AWWB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BACTERIAL ENDOPHTHALMITIS 23 0.0865
1 HEREDITARY HAEMORRHAGIC TELANGIECTASIA 3 0.0306
2 RECTAL CANCER METASTATIC 6 0.0172
3 INTERCEPTED PRODUCT ADMINISTRATION ERROR 98 0.0128
4 PRODUCT SUBSTITUTION 5 0.0124
5 CARDIORENAL SYNDROME 6 0.0105
6 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 346 0.0102
7 AGE-RELATED MACULAR DEGENERATION 14 0.0092
8 GLIOBLASTOMA 15 0.0088
9 INTERCEPTED PRODUCT SELECTION ERROR 10 0.0077
See all enriched reactions for BEVACIZUMAB-AWWB